CN106102755B - 用于产生视黄酸的试剂 - Google Patents
用于产生视黄酸的试剂 Download PDFInfo
- Publication number
- CN106102755B CN106102755B CN201580013813.7A CN201580013813A CN106102755B CN 106102755 B CN106102755 B CN 106102755B CN 201580013813 A CN201580013813 A CN 201580013813A CN 106102755 B CN106102755 B CN 106102755B
- Authority
- CN
- China
- Prior art keywords
- agent
- retinoic acid
- lactic acid
- present
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 title claims abstract description 75
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 75
- 229930002330 retinoic acid Natural products 0.000 title claims abstract description 75
- 229960001727 tretinoin Drugs 0.000 title claims abstract description 75
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 136
- 241000894006 Bacteria Species 0.000 claims description 73
- 235000014655 lactic acid Nutrition 0.000 claims description 68
- 239000004310 lactic acid Substances 0.000 claims description 68
- 230000036737 immune function Effects 0.000 claims description 47
- 230000002708 enhancing effect Effects 0.000 claims description 37
- 238000004519 manufacturing process Methods 0.000 claims description 27
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 14
- 210000005210 lymphoid organ Anatomy 0.000 claims description 5
- 210000000987 immune system Anatomy 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 abstract description 10
- 229940039696 lactobacillus Drugs 0.000 abstract description 9
- 230000001939 inductive effect Effects 0.000 abstract description 8
- 239000004480 active ingredient Substances 0.000 abstract description 7
- 230000007246 mechanism Effects 0.000 abstract description 3
- 230000000091 immunopotentiator Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 36
- 208000035473 Communicable disease Diseases 0.000 description 31
- 208000015181 infectious disease Diseases 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- 241000124008 Mammalia Species 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 230000000968 intestinal effect Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- 108010027691 Retinal dehydrogenase Proteins 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 210000001165 lymph node Anatomy 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 238000001727 in vivo Methods 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 10
- 235000013336 milk Nutrition 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- 210000004080 milk Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 101150030879 ALDH1A2 gene Proteins 0.000 description 8
- 241000233866 Fungi Species 0.000 description 8
- 241000700605 Viruses Species 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 8
- 210000004443 dendritic cell Anatomy 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 102000018822 Retinal Dehydrogenase Human genes 0.000 description 6
- 210000000813 small intestine Anatomy 0.000 description 6
- 206010009900 Colitis ulcerative Diseases 0.000 description 5
- 208000011231 Crohn disease Diseases 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 5
- 102100022297 Integrin alpha-X Human genes 0.000 description 5
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 5
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 5
- 201000006704 Ulcerative Colitis Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 210000004102 animal cell Anatomy 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000007123 defense Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000020185 raw untreated milk Nutrition 0.000 description 5
- 206010070545 Bacterial translocation Diseases 0.000 description 4
- 241000590002 Helicobacter pylori Species 0.000 description 4
- 206010028116 Mucosal inflammation Diseases 0.000 description 4
- 201000010927 Mucositis Diseases 0.000 description 4
- 102100040070 Retinal dehydrogenase 2 Human genes 0.000 description 4
- 230000007375 bacterial translocation Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229940037467 helicobacter pylori Drugs 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 244000039328 opportunistic pathogen Species 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000003289 regulatory T cell Anatomy 0.000 description 4
- 235000020945 retinal Nutrition 0.000 description 4
- 239000011604 retinal Substances 0.000 description 4
- 230000002207 retinal effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- 229920002444 Exopolysaccharide Polymers 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000013861 fat-free Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000021243 milk fat Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194024 Streptococcus salivarius Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 108010035291 retinol dehydrogenase Proteins 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102100026663 All-trans-retinol dehydrogenase [NAD(+)] ADH7 Human genes 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241001125840 Coryphaenidae Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000282818 Giraffidae Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000289619 Macropodidae Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241000282335 Procyon Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001147416 Ursus maritimus Species 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 210000004544 dc2 Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 210000000883 ear external Anatomy 0.000 description 1
- 210000000959 ear middle Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014051065 | 2014-03-14 | ||
| JP2014-051065 | 2014-03-14 | ||
| PCT/JP2015/057560 WO2015137501A1 (ja) | 2014-03-14 | 2015-03-13 | レチノイン酸産生剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106102755A CN106102755A (zh) | 2016-11-09 |
| CN106102755B true CN106102755B (zh) | 2020-02-21 |
Family
ID=54071936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201580013813.7A Active CN106102755B (zh) | 2014-03-14 | 2015-03-13 | 用于产生视黄酸的试剂 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP6543614B2 (ja) |
| CN (1) | CN106102755B (ja) |
| HK (1) | HK1226296A1 (ja) |
| SG (1) | SG11201607674SA (ja) |
| WO (1) | WO2015137501A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6892079B2 (ja) * | 2017-06-29 | 2021-06-18 | 京都府公立大学法人 | 制御性ｔ細胞誘導剤、アジュバント及び食品組成物 |
| WO2022075096A1 (ja) * | 2020-10-07 | 2022-04-14 | 株式会社 資生堂 | Ｒａｌｄｈ２発現増強剤 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102647991A (zh) * | 2009-11-25 | 2012-08-22 | 株式会社明治 | 抗病毒剂和饮食品组合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5571941B2 (ja) * | 2009-12-14 | 2014-08-13 | 雪印メグミルク株式会社 | 制御性ｔ細胞増加剤 |
-
2015
- 2015-03-13 SG SG11201607674SA patent/SG11201607674SA/en unknown
- 2015-03-13 HK HK16114569.4A patent/HK1226296A1/zh unknown
- 2015-03-13 WO PCT/JP2015/057560 patent/WO2015137501A1/ja active Application Filing
- 2015-03-13 JP JP2016507856A patent/JP6543614B2/ja active Active
- 2015-03-13 CN CN201580013813.7A patent/CN106102755B/zh active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102647991A (zh) * | 2009-11-25 | 2012-08-22 | 株式会社明治 | 抗病毒剂和饮食品组合物 |
Non-Patent Citations (2)
| Title |
|---|
| Immunomodulatory Effects of Polysaccharides Produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1;S. Makino等;《Journal of Dairy Science》;20061231;第89卷;第2873-2881页 * |
| Oral supplementation with Lactobacillus delbrueckiisubsp. bulgaricus 8481 enhances systemic immunity in elderly subjects;Marco Antonio Moro-García等;《AGE》;20131231;第35卷;第1311-1326页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1226296A1 (zh) | 2017-09-29 |
| JPWO2015137501A1 (ja) | 2017-04-06 |
| JP6543614B2 (ja) | 2019-07-10 |
| SG11201607674SA (en) | 2016-11-29 |
| CN106102755A (zh) | 2016-11-09 |
| WO2015137501A1 (ja) | 2015-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5718916B2 (ja) | 新規なラクトバチルス・プランタラム及びこれを含む組成物 | |
| EP2123168B1 (en) | Lactobacillus paracasei and weight control | |
| DK2478910T3 (en) | ANTI-ADIPOSITY AGENT, ANTI-ADIPOSITA NUTRITION OR DRINK, GLUCOSE TOLERANCE EFFECTIVE AGENT, AND NUTRITION OR DRINK FOR IMPROVING GLUCOSE TOLERANCE | |
| EP2586448B1 (en) | Skin properties improving agent for oral administration | |
| JP6329125B2 (ja) | ストレス軽減剤 | |
| RU2704133C2 (ru) | Применение lactobacillus paracasei для усиления восстановления разнообразия кишечной микрофлоры после дисбактериоза | |
| JP2012510291A (ja) | 新規なラクトバチルス・プランタラム及びこれを含む組成物 | |
| MX2013005371A (es) | Micro-organismos probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior. | |
| WO2013031749A1 (ja) | 身体活動を促進させる乳酸菌 | |
| CA2886244A1 (en) | Probiotic and prebiotic compositions | |
| JP6923883B2 (ja) | 栄養状態改善に使用するための組成物 | |
| JP7060555B2 (ja) | ビフィドバクテリウムラクティスｇｋｋ２の活性物質、それを含む組成物及びそれによって長寿命化を促進する方法 | |
| WO2018190407A1 (ja) | Ｔｏｌｌ様受容体２活性化用組成物 | |
| CN117460428A (zh) | Gos预调理的罗伊氏乳杆菌和最终制剂中的gos | |
| KR20240130711A (ko) | 불안 장애의 치료 및/또는 예방에 있어서 포스트바이오틱스의 용도 | |
| HK1225637A1 (zh) | 功能性消化道障礙預防和/或改善劑 | |
| US12083152B2 (en) | Agent for improving mitochondrial function | |
| Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
| CN106102755B (zh) | 用于产生视黄酸的试剂 | |
| KR20240037256A (ko) | 생리학적으로 허용되는 효모 조성물 및 이의 용도 | |
| US8728794B2 (en) | Strain conferring anti-disease properties to host and bacterial cell composition | |
| US8980289B2 (en) | Intestine immunomodulator | |
| Ezema et al. | Yeast (Saccharomyces cerevisiae) as a probiotic of choice for broiler production | |
| JP2014166972A (ja) | 腸炎抑制剤及び飲食品 | |
| JP6894096B2 (ja) | 軟骨再生促進用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1226296 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1226296 Country of ref document: HK |